| HOME >> BIOLOGY >> TECHNOLOGY |
At June 30, 2007, the company recorded an accrual of $2.4 million
($1.6 million sales tax and $.8 million in interest) for the
anticipated amount of the settlement, which was paid in the third
quarter 2007.
h) Biosite Break-Up Fee -- On May 17, 2007 the merger agreement to acquire
Biosite, Inc. was terminated by Biosite in accordance with its terms.
Pursuant to the terms of the agreement, Biosite paid the company a
break up fee of $54 million. The company recorded a gain of $40.6
million (net of associated expenses of $13.4 million) in other
non-operating income during the second quarter.
i) Investigation Charges -- During the second quarter 2006, the Audit and
Finance Committee of the company's Board of Directors oversaw an
investigation of claims made by a former employee. This individual
alleged that his recent termination, as part of the company's
restructuring, was the result of certain accounting issues he brought
to the attention of his supervisor. The Audit and Finance Committee
retained outside counsel and an independent accounting firm to assist
in the investigation and concluded that the allegations were not
substantiated and that the company's financial statements and
disclosures did not require revision. Approximately $2.9 million in
legal, consulting and independent accounting firm fees were incurred
during the second quarter of 2006 in connection with this
investigation.
j) Applera -- In April, 2006, a settlement was reached in a legal dispute
with Applera Corporation whereby the parties granted royalty-bearing
licenses to each other for certain patents. Applera's Applied
Biosystems Group made a $35.0 million special payment to the company.
'/>"/>
| SOURCE Beckman Coulter, Inc. Copyright©2007 PR Newswire. All rights reserved |